 HAYWARD, Calif.--BUSINESS WIRE--Pulse Biosciences, Inc. Nasdaq: PLSE Pulse Biosciences or the Company, a novel bioelectric medicine company progressing Nano-Pulse StimulationTM NPSTM technology, today announced Conformité Européene CE mark approval for the CellFX System. The CE mark confirms that the CellFX System meets the requirements of the European Medical Devices Directive. This allows the Company to proceed with its planned controlled launch of the CellFX System to medical pr 